

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.01521141 |
| 2 | axon ensheathment (GO:0008366) | 6.24999275 |
| 3 | ensheathment of neurons (GO:0007272) | 6.24999275 |
| 4 | myelination (GO:0042552) | 6.23919399 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.63338117 |
| 6 | myelin maintenance (GO:0043217) | 5.08746674 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.89345750 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 4.84405784 |
| 9 | cholesterol biosynthetic process (GO:0006695) | 4.80995630 |
| 10 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.54010296 |
| 11 | negative regulation of neurotransmitter transport (GO:0051589) | 4.36215386 |
| 12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.32205037 |
| 13 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.27777659 |
| 14 | creatine metabolic process (GO:0006600) | 4.27474775 |
| 15 | sterol biosynthetic process (GO:0016126) | 4.26998776 |
| 16 | response to peptidoglycan (GO:0032494) | 4.23285410 |
| 17 | response to methylmercury (GO:0051597) | 4.22382000 |
| 18 | glycerophospholipid catabolic process (GO:0046475) | 4.21128776 |
| 19 | oligodendrocyte differentiation (GO:0048709) | 4.19224602 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.18098703 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18098703 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18098703 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18098703 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 4.18098703 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18098703 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 4.17584462 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 4.16932131 |
| 28 | negative regulation of protein localization to cell surface (GO:2000009) | 4.11455559 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.09673739 |
| 30 | regulation of collateral sprouting (GO:0048670) | 4.02754485 |
| 31 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.96769986 |
| 32 | L-amino acid import (GO:0043092) | 3.93471740 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.89199410 |
| 34 | L-phenylalanine catabolic process (GO:0006559) | 3.89199410 |
| 35 | amyloid precursor protein metabolic process (GO:0042982) | 3.88419489 |
| 36 | establishment of mitochondrion localization (GO:0051654) | 3.88145085 |
| 37 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.86469510 |
| 38 | microglial cell activation (GO:0001774) | 3.81605502 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81002360 |
| 40 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.80516741 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.77707109 |
| 42 | very long-chain fatty acid metabolic process (GO:0000038) | 3.76364199 |
| 43 | import into cell (GO:0098657) | 3.75236392 |
| 44 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.72491100 |
| 45 | apical protein localization (GO:0045176) | 3.72442080 |
| 46 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.72031500 |
| 47 | eye photoreceptor cell differentiation (GO:0001754) | 3.71886073 |
| 48 | photoreceptor cell differentiation (GO:0046530) | 3.71886073 |
| 49 | macrophage activation (GO:0042116) | 3.70702915 |
| 50 | detection of other organism (GO:0098543) | 3.70032223 |
| 51 | regulation of lipoprotein metabolic process (GO:0050746) | 3.66104868 |
| 52 | isoprenoid biosynthetic process (GO:0008299) | 3.65994143 |
| 53 | cellular extravasation (GO:0045123) | 3.65039602 |
| 54 | response to lipoprotein particle (GO:0055094) | 3.62299303 |
| 55 | presynaptic membrane organization (GO:0097090) | 3.59791270 |
| 56 | asymmetric protein localization (GO:0008105) | 3.56873542 |
| 57 | astrocyte development (GO:0014002) | 3.55118156 |
| 58 | oligosaccharide catabolic process (GO:0009313) | 3.54245520 |
| 59 | negative regulation of cell killing (GO:0031342) | 3.52139788 |
| 60 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52139788 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.49558161 |
| 62 | response to redox state (GO:0051775) | 3.48933260 |
| 63 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.46821619 |
| 64 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.41247323 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 3.40848078 |
| 66 | adhesion of symbiont to host cell (GO:0044650) | 3.40815051 |
| 67 | virion attachment to host cell (GO:0019062) | 3.40815051 |
| 68 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.39298424 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.37994629 |
| 70 | neutrophil activation (GO:0042119) | 3.34939137 |
| 71 | presynaptic membrane assembly (GO:0097105) | 3.30586979 |
| 72 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.30367756 |
| 73 | positive regulation of mast cell degranulation (GO:0043306) | 3.30367756 |
| 74 | granulocyte activation (GO:0036230) | 3.28794312 |
| 75 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.27778582 |
| 76 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.27018245 |
| 77 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.26192778 |
| 78 | L-phenylalanine metabolic process (GO:0006558) | 3.26192778 |
| 79 | glycosphingolipid catabolic process (GO:0046479) | 3.24962382 |
| 80 | negative regulation of interleukin-17 production (GO:0032700) | 3.23977630 |
| 81 | heme transport (GO:0015886) | 3.23397825 |
| 82 | acyl-CoA biosynthetic process (GO:0071616) | 3.19727682 |
| 83 | thioester biosynthetic process (GO:0035384) | 3.19727682 |
| 84 | membrane tubulation (GO:0097320) | 3.18583132 |
| 85 | substantia nigra development (GO:0021762) | 3.18241675 |
| 86 | amyloid precursor protein catabolic process (GO:0042987) | 3.17154144 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16240592 |
| 88 | nucleotide transmembrane transport (GO:1901679) | 3.14544505 |
| 89 | detection of bacterium (GO:0016045) | 3.07924768 |
| 90 | GPI anchor biosynthetic process (GO:0006506) | 3.07606756 |
| 91 | GPI anchor metabolic process (GO:0006505) | 3.05914378 |
| 92 | regulation of mast cell degranulation (GO:0043304) | 3.05721763 |
| 93 | respiratory burst (GO:0045730) | 3.04298541 |
| 94 | amino sugar catabolic process (GO:0046348) | 3.04257210 |
| 95 | iron coordination entity transport (GO:1901678) | 3.03736553 |
| 96 | T-helper 1 type immune response (GO:0042088) | 3.03715321 |
| 97 | response to host immune response (GO:0052572) | 3.03364396 |
| 98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.03364396 |
| 99 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.01969260 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 3.01896303 |
| 101 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99853476 |
| 102 | regulation of mast cell activation (GO:0033003) | 2.99437189 |
| 103 | axon development (GO:0061564) | 2.98636962 |
| 104 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.98182706 |
| 105 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.97751836 |
| 106 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.96824391 |
| 107 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96799990 |
| 108 | protein palmitoylation (GO:0018345) | 2.95609359 |
| 109 | regulation of mononuclear cell migration (GO:0071675) | 2.95518569 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95347871 |
| 111 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.95342518 |
| 112 | glycolipid catabolic process (GO:0019377) | 2.93470329 |
| 113 | glycosylceramide metabolic process (GO:0006677) | 2.89050485 |
| 114 | positive regulation of macrophage cytokine production (GO:0060907) | 2.88626497 |
| 115 | myelination in peripheral nervous system (GO:0022011) | 2.87682879 |
| 116 | peripheral nervous system axon ensheathment (GO:0032292) | 2.87682879 |
| 117 | amino acid import (GO:0043090) | 2.85259585 |
| 118 | neutrophil mediated immunity (GO:0002446) | 2.84751807 |
| 119 | magnesium ion transport (GO:0015693) | 2.83789214 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83497951 |
| 121 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.81308484 |
| 122 | neutrophil chemotaxis (GO:0030593) | 2.80940095 |
| 123 | adult walking behavior (GO:0007628) | 2.79147757 |
| 124 | cellular response to ethanol (GO:0071361) | 2.77202903 |
| 125 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74261129 |
| 126 | neutrophil migration (GO:1990266) | 2.73794589 |
| 127 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.73010944 |
| 128 | negative regulation of JUN kinase activity (GO:0043508) | 2.72220248 |
| 129 | neuron remodeling (GO:0016322) | 2.70217792 |
| 130 | negative regulation of acute inflammatory response (GO:0002674) | 2.69522721 |
| 131 | ceramide catabolic process (GO:0046514) | 2.69304048 |
| 132 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.69115784 |
| 133 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.68914693 |
| 134 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.68082830 |
| 135 | phagosome maturation (GO:0090382) | 2.67940882 |
| 136 | cellular response to type I interferon (GO:0071357) | 2.65411646 |
| 137 | type I interferon signaling pathway (GO:0060337) | 2.65411646 |
| 138 | regulation of macrophage chemotaxis (GO:0010758) | 2.65224364 |
| 139 | regulation of interferon-alpha production (GO:0032647) | 2.65088409 |
| 140 | granulocyte chemotaxis (GO:0071621) | 2.64466330 |
| 141 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.63158180 |
| 142 | regulation of podosome assembly (GO:0071801) | 2.62779581 |
| 143 | B cell mediated immunity (GO:0019724) | 2.62216523 |
| 144 | adhesion of symbiont to host (GO:0044406) | 2.62114286 |
| 145 | neurotransmitter uptake (GO:0001504) | 2.61099863 |
| 146 | regulation of leukocyte degranulation (GO:0043300) | 2.60718029 |
| 147 | negative regulation of lipid storage (GO:0010888) | 2.59970854 |
| 148 | defense response to protozoan (GO:0042832) | 2.59771745 |
| 149 | response to lead ion (GO:0010288) | 2.59584969 |
| 150 | response to type I interferon (GO:0034340) | 2.59236059 |
| 151 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.58552770 |
| 152 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.57532794 |
| 153 | response to host (GO:0075136) | 2.57532794 |
| 154 | response to host defenses (GO:0052200) | 2.57532794 |
| 155 | positive regulation of interferon-alpha production (GO:0032727) | 2.56929610 |
| 156 | nucleotide transport (GO:0006862) | 2.55223999 |
| 157 | myeloid leukocyte activation (GO:0002274) | 2.55125644 |
| 158 | acyl-CoA metabolic process (GO:0006637) | 2.54822405 |
| 159 | thioester metabolic process (GO:0035383) | 2.54822405 |
| 160 | positive regulation of glial cell differentiation (GO:0045687) | 2.54806204 |
| 161 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.54324607 |
| 162 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.54236399 |
| 163 | regulation of beta-amyloid formation (GO:1902003) | 2.53965084 |
| 164 | peptidyl-cysteine modification (GO:0018198) | 2.52821720 |
| 165 | granulocyte migration (GO:0097530) | 2.52710734 |
| 166 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.52249087 |
| 167 | regulation of macrophage cytokine production (GO:0010935) | 2.52085650 |
| 168 | cholesterol metabolic process (GO:0008203) | 2.51836406 |
| 169 | glutathione biosynthetic process (GO:0006750) | 2.51804113 |
| 170 | negative regulation of macroautophagy (GO:0016242) | 2.51074848 |
| 171 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.51000260 |
| 172 | superoxide anion generation (GO:0042554) | 2.49597784 |
| 173 | positive regulation of type 2 immune response (GO:0002830) | 2.49262523 |
| 174 | positive regulation of interleukin-6 production (GO:0032755) | 2.48523634 |
| 175 | limb bud formation (GO:0060174) | 2.47296595 |
| 176 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.45860776 |
| 177 | regulation of T cell tolerance induction (GO:0002664) | 2.45700144 |
| 178 | negative regulation of axonogenesis (GO:0050771) | 2.44674474 |
| 179 | myeloid leukocyte mediated immunity (GO:0002444) | 2.44594488 |
| 180 | glial cell development (GO:0021782) | 2.44225751 |
| 181 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.43950081 |
| 182 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.43733722 |
| 183 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.43508045 |
| 184 | membrane raft organization (GO:0031579) | 2.42910794 |
| 185 | protein neddylation (GO:0045116) | 2.42807619 |
| 186 | positive regulation of action potential (GO:0045760) | 2.42712834 |
| 187 | neuron cell-cell adhesion (GO:0007158) | 2.40378991 |
| 188 | tissue regeneration (GO:0042246) | 2.39929397 |
| 189 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.39837919 |
| 190 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.39050800 |
| 191 | response to dietary excess (GO:0002021) | 2.36487286 |
| 192 | peripheral nervous system development (GO:0007422) | 2.36112286 |
| 193 | mannosylation (GO:0097502) | 2.34801713 |
| 194 | positive regulation of gliogenesis (GO:0014015) | 2.34186134 |
| 195 | cofactor catabolic process (GO:0051187) | 2.33994478 |
| 196 | nerve growth factor signaling pathway (GO:0038180) | 2.32744614 |
| 197 | sterol metabolic process (GO:0016125) | 2.32319044 |
| 198 | axon ensheathment in central nervous system (GO:0032291) | 11.1188781 |
| 199 | central nervous system myelination (GO:0022010) | 11.1188781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.61787224 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.12169355 |
| 3 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.41156613 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.39370971 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21976504 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18299170 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94144801 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.74603724 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63898984 |
| 10 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.61487256 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49907632 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.48033978 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44901453 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.41174472 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40672749 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.39228500 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31398284 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.28358796 |
| 19 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.16889844 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01046515 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.00963081 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.98597756 |
| 23 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.96731678 |
| 24 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.96051431 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95761888 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91646779 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.88389903 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.80131677 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.75103229 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.74636691 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.73318471 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73155501 |
| 33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69412134 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68713057 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68036162 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67761470 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64642556 |
| 38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.64517588 |
| 39 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.63526293 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.62269372 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61895588 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61700161 |
| 43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61150575 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.58051965 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.58051965 |
| 46 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.57745631 |
| 47 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.57389661 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57105625 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55835676 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54288961 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54288961 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54089347 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.52153084 |
| 54 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47202801 |
| 55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.46414310 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46080726 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44266828 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.43990686 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40232771 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38328083 |
| 61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35252688 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35050456 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32745795 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.31896317 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30379826 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29034103 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28001387 |
| 68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27833609 |
| 69 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.27755919 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27601414 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26713451 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25050832 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24313294 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24028706 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23830121 |
| 76 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.22377719 |
| 77 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22184370 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20944452 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20383316 |
| 80 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20024481 |
| 81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19713193 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19673736 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17997915 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17441055 |
| 85 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17136031 |
| 86 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17122969 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16871957 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16852669 |
| 89 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.16540886 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16516174 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16323762 |
| 92 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14978948 |
| 93 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11041825 |
| 94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10377954 |
| 95 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09847321 |
| 96 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09845632 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09622738 |
| 98 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09384668 |
| 99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09256276 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08958224 |
| 101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08828975 |
| 102 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08579592 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08281217 |
| 104 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06025370 |
| 105 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05981163 |
| 106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05720377 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.04858188 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04763767 |
| 109 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04552128 |
| 110 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04471584 |
| 111 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.04373701 |
| 112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03723232 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03233703 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03183743 |
| 115 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02936315 |
| 116 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01820011 |
| 117 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01165882 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01164568 |
| 119 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00357113 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99964969 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99953640 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99848639 |
| 123 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.99689947 |
| 124 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99671761 |
| 125 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99475600 |
| 126 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99475600 |
| 127 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99450987 |
| 128 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.99234756 |
| 129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98372058 |
| 130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98243177 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97757809 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97471232 |
| 133 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97440510 |
| 134 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97230116 |
| 135 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96585668 |
| 136 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96503068 |
| 137 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96294481 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95830626 |
| 139 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95579051 |
| 140 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95512152 |
| 141 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95300880 |
| 142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95051238 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94607433 |
| 144 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.93575964 |
| 145 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93573128 |
| 146 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92835148 |
| 147 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92735105 |
| 148 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91636628 |
| 149 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91125316 |
| 150 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90897189 |
| 151 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.90829172 |
| 152 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.90210814 |
| 153 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89615239 |
| 154 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89379644 |
| 155 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89088644 |
| 156 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.88460876 |
| 157 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87435446 |
| 158 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.87405748 |
| 159 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.87278065 |
| 160 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.87059756 |
| 161 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86895265 |
| 162 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86881672 |
| 163 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.86876364 |
| 164 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.86778022 |
| 165 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.86320929 |
| 166 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86189551 |
| 167 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86136342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.56899701 |
| 2 | MP0003724_increased_susceptibility_to | 4.47633632 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.84912630 |
| 4 | MP0003303_peritoneal_inflammation | 3.67535383 |
| 5 | MP0003690_abnormal_glial_cell | 3.58216320 |
| 6 | MP0003880_abnormal_central_pattern | 3.26482695 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.17964133 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.00005150 |
| 9 | MP0003329_amyloid_beta_deposits | 2.78523102 |
| 10 | MP0009785_altered_susceptibility_to | 2.69239662 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.65268013 |
| 12 | MP0004270_analgesia | 2.64557301 |
| 13 | MP0002419_abnormal_innate_immunity | 2.62653444 |
| 14 | MP0003436_decreased_susceptibility_to | 2.59007167 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.55843425 |
| 16 | MP0005171_absent_coat_pigmentation | 2.54831119 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.49477716 |
| 18 | MP0004885_abnormal_endolymph | 2.44027862 |
| 19 | MP0001529_abnormal_vocalization | 2.43824383 |
| 20 | MP0003136_yellow_coat_color | 2.39232159 |
| 21 | MP0003634_abnormal_glial_cell | 2.35322362 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.32701399 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.26992936 |
| 24 | MP0001905_abnormal_dopamine_level | 2.26980014 |
| 25 | MP0005671_abnormal_response_to | 2.20826010 |
| 26 | MP0004142_abnormal_muscle_tone | 2.17335131 |
| 27 | MP0004742_abnormal_vestibular_system | 2.14938143 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.13859083 |
| 29 | MP0001486_abnormal_startle_reflex | 2.13466606 |
| 30 | MP0002272_abnormal_nervous_system | 2.12793676 |
| 31 | MP0005387_immune_system_phenotype | 2.11149116 |
| 32 | MP0001790_abnormal_immune_system | 2.11149116 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 2.08062414 |
| 34 | MP0005025_abnormal_response_to | 2.06569998 |
| 35 | MP0004043_abnormal_pH_regulation | 2.01060081 |
| 36 | MP0003195_calcinosis | 2.00578500 |
| 37 | MP0002064_seizures | 1.88999681 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.87832923 |
| 39 | MP0005451_abnormal_body_composition | 1.85740975 |
| 40 | MP0000604_amyloidosis | 1.85086466 |
| 41 | MP0009764_decreased_sensitivity_to | 1.83831885 |
| 42 | MP0005409_darkened_coat_color | 1.82910644 |
| 43 | MP0000685_abnormal_immune_system | 1.82885824 |
| 44 | MP0002723_abnormal_immune_serum | 1.82103499 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.81298725 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.79599025 |
| 47 | MP0002229_neurodegeneration | 1.78589558 |
| 48 | MP0001800_abnormal_humoral_immune | 1.77093709 |
| 49 | MP0003632_abnormal_nervous_system | 1.73481266 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.71325161 |
| 51 | MP0000343_altered_response_to | 1.70040023 |
| 52 | MP0009840_abnormal_foam_cell | 1.68634769 |
| 53 | MP0005410_abnormal_fertilization | 1.66761361 |
| 54 | MP0001485_abnormal_pinna_reflex | 1.64646814 |
| 55 | MP0004381_abnormal_hair_follicle | 1.61225249 |
| 56 | MP0010678_abnormal_skin_adnexa | 1.61089849 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.57466028 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.56682450 |
| 59 | MP0001819_abnormal_immune_cell | 1.55575488 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.52477998 |
| 61 | MP0000778_abnormal_nervous_system | 1.52080280 |
| 62 | MP0000383_abnormal_hair_follicle | 1.50230125 |
| 63 | MP0004883_abnormal_blood_vessel | 1.49695871 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.49401723 |
| 65 | MP0008260_abnormal_autophagy | 1.48272789 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.46607281 |
| 67 | MP0009046_muscle_twitch | 1.45245546 |
| 68 | MP0003631_nervous_system_phenotype | 1.42549499 |
| 69 | MP0006054_spinal_hemorrhage | 1.42365064 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.40786223 |
| 71 | MP0003828_pulmonary_edema | 1.40560588 |
| 72 | MP0002405_respiratory_system_inflammati | 1.39939827 |
| 73 | MP0005423_abnormal_somatic_nervous | 1.38460439 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.38016342 |
| 75 | MP0003633_abnormal_nervous_system | 1.35188622 |
| 76 | MP0008469_abnormal_protein_level | 1.34984529 |
| 77 | MP0009745_abnormal_behavioral_response | 1.34613637 |
| 78 | MP0004147_increased_porphyrin_level | 1.33734955 |
| 79 | MP0005248_abnormal_Harderian_gland | 1.32965754 |
| 80 | MP0005166_decreased_susceptibility_to | 1.32116681 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 1.30998881 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.30475154 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 1.29148251 |
| 84 | MP0001661_extended_life_span | 1.28931025 |
| 85 | MP0005360_urolithiasis | 1.26273550 |
| 86 | MP0006082_CNS_inflammation | 1.24343849 |
| 87 | MP0004134_abnormal_chest_morphology | 1.21800710 |
| 88 | MP0000566_synostosis | 1.20786219 |
| 89 | MP0000462_abnormal_digestive_system | 1.20728157 |
| 90 | MP0003635_abnormal_synaptic_transmissio | 1.18657993 |
| 91 | MP0001853_heart_inflammation | 1.18639377 |
| 92 | MP0010155_abnormal_intestine_physiology | 1.16544257 |
| 93 | MP0003448_altered_tumor_morphology | 1.16338485 |
| 94 | MP0004859_abnormal_synaptic_plasticity | 1.15582545 |
| 95 | MP0005310_abnormal_salivary_gland | 1.14626785 |
| 96 | MP0001440_abnormal_grooming_behavior | 1.10230614 |
| 97 | MP0001346_abnormal_lacrimal_gland | 1.08819168 |
| 98 | MP0002254_reproductive_system_inflammat | 1.06794063 |
| 99 | MP0000955_abnormal_spinal_cord | 1.03772871 |
| 100 | MP0001963_abnormal_hearing_physiology | 1.03060444 |
| 101 | MP0005332_abnormal_amino_acid | 1.02654014 |
| 102 | MP0004947_skin_inflammation | 1.02476808 |
| 103 | MP0001851_eye_inflammation | 1.02060010 |
| 104 | MP0002572_abnormal_emotion/affect_behav | 1.01621595 |
| 105 | MP0005408_hypopigmentation | 1.01561045 |
| 106 | MP0002882_abnormal_neuron_morphology | 1.00704359 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 1.00693409 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.99463541 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.99463541 |
| 110 | MP0000371_diluted_coat_color | 0.99090118 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.98207087 |
| 112 | MP0000716_abnormal_immune_system | 0.97814996 |
| 113 | MP0000747_muscle_weakness | 0.97557166 |
| 114 | MP0001970_abnormal_pain_threshold | 0.97381918 |
| 115 | MP0008569_lethality_at_weaning | 0.97283510 |
| 116 | MP0005195_abnormal_posterior_eye | 0.96935253 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.96391610 |
| 118 | MP0008004_abnormal_stomach_pH | 0.96346187 |
| 119 | MP0002090_abnormal_vision | 0.96236341 |
| 120 | MP0004510_myositis | 0.95356680 |
| 121 | MP0005386_behavior/neurological_phenoty | 0.94484853 |
| 122 | MP0004924_abnormal_behavior | 0.94484853 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.94033541 |
| 124 | MP0000647_abnormal_sebaceous_gland | 0.93836819 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.93560094 |
| 126 | MP0002067_abnormal_sensory_capabilities | 0.93108541 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.92680971 |
| 128 | MP0001177_atelectasis | 0.90280893 |
| 129 | MP0003011_delayed_dark_adaptation | 0.89695795 |
| 130 | MP0005085_abnormal_gallbladder_physiolo | 0.88899873 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87782050 |
| 132 | MP0002063_abnormal_learning/memory/cond | 0.85195021 |
| 133 | MP0002752_abnormal_somatic_nervous | 0.84962526 |
| 134 | MP0002332_abnormal_exercise_endurance | 0.84599943 |
| 135 | MP0003075_altered_response_to | 0.83387293 |
| 136 | MP0001299_abnormal_eye_distance/ | 0.81657038 |
| 137 | MP0009763_increased_sensitivity_to | 0.80651496 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.78430775 |
| 139 | MP0005075_abnormal_melanosome_morpholog | 0.78426832 |
| 140 | MP0000015_abnormal_ear_pigmentation | 0.77379373 |
| 141 | MP0004484_altered_response_of | 0.76629283 |
| 142 | MP0000579_abnormal_nail_morphology | 0.76289753 |
| 143 | MP0005174_abnormal_tail_pigmentation | 0.75759071 |
| 144 | MP0001324_abnormal_eye_pigmentation | 0.75469744 |
| 145 | MP0000249_abnormal_blood_vessel | 0.75242227 |
| 146 | MP0000689_abnormal_spleen_morphology | 0.74960930 |
| 147 | MP0000372_irregular_coat_pigmentation | 0.74311062 |
| 148 | MP0002166_altered_tumor_susceptibility | 0.73876397 |
| 149 | MP0000858_altered_metastatic_potential | 0.71123812 |
| 150 | MP0004036_abnormal_muscle_relaxation | 0.69363177 |
| 151 | MP0005535_abnormal_body_temperature | 0.69163448 |
| 152 | MP0005623_abnormal_meninges_morphology | 0.67985074 |
| 153 | MP0002733_abnormal_thermal_nociception | 0.66872114 |
| 154 | MP0002398_abnormal_bone_marrow | 0.65489211 |
| 155 | MP0002133_abnormal_respiratory_system | 0.65483669 |
| 156 | MP0005388_respiratory_system_phenotype | 0.65483669 |
| 157 | MP0003866_abnormal_defecation | 0.65369555 |
| 158 | MP0005165_increased_susceptibility_to | 0.64836106 |
| 159 | MP0002736_abnormal_nociception_after | 0.64687141 |
| 160 | MP0005253_abnormal_eye_physiology | 0.64432900 |
| 161 | MP0005376_homeostasis/metabolism_phenot | 0.64278304 |
| 162 | MP0005083_abnormal_biliary_tract | 0.62832456 |
| 163 | MP0002429_abnormal_blood_cell | 0.62558567 |
| 164 | MP0001968_abnormal_touch/_nociception | 0.62520627 |
| 165 | MP0002971_abnormal_brown_adipose | 0.60897440 |
| 166 | MP0005164_abnormal_response_to | 0.59100774 |
| 167 | MP0000762_abnormal_tongue_morphology | 0.58946507 |
| 168 | MP0000639_abnormal_adrenal_gland | 0.58550495 |
| 169 | MP0005365_abnormal_bile_salt | 0.58311033 |
| 170 | MP0000026_abnormal_inner_ear | 0.58128125 |
| 171 | MP0001502_abnormal_circadian_rhythm | 0.57371847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.57739621 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.29455500 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.29455500 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.26397485 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.26397485 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 6.26397485 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.85962509 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.79940146 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.69433643 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 4.63088353 |
| 11 | Abnormality of the corticospinal tract (HP:0002492) | 4.60277110 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.59609710 |
| 13 | Parakeratosis (HP:0001036) | 4.58454681 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.20584289 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.14448902 |
| 16 | Sensory axonal neuropathy (HP:0003390) | 4.13134799 |
| 17 | Peripheral hypomyelination (HP:0007182) | 3.90859622 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.85875394 |
| 19 | Optic neuritis (HP:0100653) | 3.85875394 |
| 20 | Stomatitis (HP:0010280) | 3.82398278 |
| 21 | Orchitis (HP:0100796) | 3.81898215 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 3.69657860 |
| 23 | Onion bulb formation (HP:0003383) | 3.61561852 |
| 24 | Myositis (HP:0100614) | 3.60877234 |
| 25 | Disinhibition (HP:0000734) | 3.60844659 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.55725566 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.54164701 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 3.52943662 |
| 29 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.50021906 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.31283369 |
| 31 | Increased serum pyruvate (HP:0003542) | 3.27545908 |
| 32 | Abnormality of glycolysis (HP:0004366) | 3.27545908 |
| 33 | Abnormal auditory evoked potentials (HP:0006958) | 3.20444071 |
| 34 | Spastic gait (HP:0002064) | 3.16723397 |
| 35 | Insidious onset (HP:0003587) | 3.07457137 |
| 36 | Termporal pattern (HP:0011008) | 3.07457137 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.06839570 |
| 38 | Intention tremor (HP:0002080) | 3.05368367 |
| 39 | Recurrent skin infections (HP:0001581) | 3.03443199 |
| 40 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.00187799 |
| 41 | Mutism (HP:0002300) | 2.97077600 |
| 42 | Cerebral hypomyelination (HP:0006808) | 2.93249635 |
| 43 | Increased CSF protein (HP:0002922) | 2.88098755 |
| 44 | Leukodystrophy (HP:0002415) | 2.87845725 |
| 45 | Dysmetria (HP:0001310) | 2.84335835 |
| 46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.82195138 |
| 47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.82195138 |
| 48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.82195138 |
| 49 | Axonal loss (HP:0003447) | 2.80010936 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.77124479 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.77124479 |
| 52 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.71935482 |
| 53 | Cerebral hemorrhage (HP:0001342) | 2.70923717 |
| 54 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.68562115 |
| 55 | Alacrima (HP:0000522) | 2.67344839 |
| 56 | Spastic paraparesis (HP:0002313) | 2.67277057 |
| 57 | Hematochezia (HP:0002573) | 2.66982854 |
| 58 | Autoamputation (HP:0001218) | 2.66819745 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.66418333 |
| 60 | Clumsiness (HP:0002312) | 2.65632897 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.65519490 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.64801555 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.62814514 |
| 64 | Scanning speech (HP:0002168) | 2.59657329 |
| 65 | Gingivitis (HP:0000230) | 2.57828345 |
| 66 | T lymphocytopenia (HP:0005403) | 2.55449323 |
| 67 | Myocardial infarction (HP:0001658) | 2.52798064 |
| 68 | Retinal dysplasia (HP:0007973) | 2.51370971 |
| 69 | Glomerulonephritis (HP:0000099) | 2.45052824 |
| 70 | Recurrent fungal infections (HP:0002841) | 2.44134420 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.43426263 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.42770050 |
| 73 | Intrahepatic cholestasis (HP:0001406) | 2.41818976 |
| 74 | Stridor (HP:0010307) | 2.41267511 |
| 75 | Ankle clonus (HP:0011448) | 2.40764479 |
| 76 | Methylmalonic acidemia (HP:0002912) | 2.39743433 |
| 77 | Akinesia (HP:0002304) | 2.39029517 |
| 78 | Metabolic alkalosis (HP:0200114) | 2.38163607 |
| 79 | Thickened helices (HP:0000391) | 2.37388341 |
| 80 | Gingival bleeding (HP:0000225) | 2.34727809 |
| 81 | Hemoptysis (HP:0002105) | 2.33285413 |
| 82 | Abnormality of T cell number (HP:0011839) | 2.33087546 |
| 83 | Purpura (HP:0000979) | 2.30381604 |
| 84 | Global brain atrophy (HP:0002283) | 2.30274655 |
| 85 | Anteriorly placed anus (HP:0001545) | 2.29123343 |
| 86 | Myokymia (HP:0002411) | 2.27055352 |
| 87 | Hypokalemic alkalosis (HP:0001949) | 2.26857406 |
| 88 | Hypoplastic pelvis (HP:0008839) | 2.24654758 |
| 89 | Hypophosphatemic rickets (HP:0004912) | 2.23888790 |
| 90 | Increased circulating renin level (HP:0000848) | 2.23411340 |
| 91 | Agnosia (HP:0010524) | 2.22394801 |
| 92 | Urticaria (HP:0001025) | 2.22235770 |
| 93 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.21871911 |
| 94 | Spastic tetraparesis (HP:0001285) | 2.21869004 |
| 95 | Patchy hypopigmentation of hair (HP:0011365) | 2.21626033 |
| 96 | Pulmonary embolism (HP:0002204) | 2.21414513 |
| 97 | Pheochromocytoma (HP:0002666) | 2.20478167 |
| 98 | Diminished motivation (HP:0000745) | 2.19265308 |
| 99 | Hyperlipoproteinemia (HP:0010980) | 2.19109323 |
| 100 | Apathy (HP:0000741) | 2.18576230 |
| 101 | Absent septum pellucidum (HP:0001331) | 2.17765427 |
| 102 | White forelock (HP:0002211) | 2.17000556 |
| 103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16776487 |
| 104 | Obstructive lung disease (HP:0006536) | 2.16776487 |
| 105 | Albinism (HP:0001022) | 2.16742782 |
| 106 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16427977 |
| 107 | Premature skin wrinkling (HP:0100678) | 2.14565795 |
| 108 | Inappropriate behavior (HP:0000719) | 2.14252693 |
| 109 | Renal Fanconi syndrome (HP:0001994) | 2.13943697 |
| 110 | Paraparesis (HP:0002385) | 2.12932869 |
| 111 | Humeroradial synostosis (HP:0003041) | 2.12455382 |
| 112 | Synostosis involving the elbow (HP:0003938) | 2.12455382 |
| 113 | Infantile muscular hypotonia (HP:0008947) | 2.09839728 |
| 114 | Hypomagnesemia (HP:0002917) | 2.09110300 |
| 115 | Polyneuropathy (HP:0001271) | 2.08624941 |
| 116 | Autoimmune thrombocytopenia (HP:0001973) | 2.08526403 |
| 117 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.08204539 |
| 118 | Split foot (HP:0001839) | 2.07446684 |
| 119 | Aplasia involving bones of the extremities (HP:0009825) | 2.07156188 |
| 120 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.07156188 |
| 121 | Aplasia of the phalanges of the hand (HP:0009802) | 2.07156188 |
| 122 | Arterial thrombosis (HP:0004420) | 2.05861201 |
| 123 | Episodic fever (HP:0001954) | 2.05505297 |
| 124 | Petechiae (HP:0000967) | 2.05449708 |
| 125 | Decreased lacrimation (HP:0000633) | 2.05205584 |
| 126 | Basal ganglia calcification (HP:0002135) | 2.04034911 |
| 127 | Prolonged neonatal jaundice (HP:0006579) | 2.03643490 |
| 128 | Coronal craniosynostosis (HP:0004440) | 2.02733929 |
| 129 | Abnormality of the periventricular white matter (HP:0002518) | 2.02164932 |
| 130 | CNS hypomyelination (HP:0003429) | 2.00858549 |
| 131 | Peripheral demyelination (HP:0011096) | 2.00013363 |
| 132 | Gangrene (HP:0100758) | 1.98796391 |
| 133 | Hypoplasia of the iris (HP:0007676) | 1.98086644 |
| 134 | Gastrointestinal infarctions (HP:0005244) | 1.97584835 |
| 135 | Vasculitis (HP:0002633) | 1.97154145 |
| 136 | Lower limb muscle weakness (HP:0007340) | 1.95565535 |
| 137 | Neuroendocrine neoplasm (HP:0100634) | 1.94555421 |
| 138 | Amyloidosis (HP:0011034) | 1.92998917 |
| 139 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92618426 |
| 140 | Interstitial pulmonary disease (HP:0006530) | 1.92499571 |
| 141 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92374925 |
| 142 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92374925 |
| 143 | 3-Methylglutaconic aciduria (HP:0003535) | 1.92152195 |
| 144 | Papillary thyroid carcinoma (HP:0002895) | 1.91623514 |
| 145 | Morphological abnormality of the inner ear (HP:0011390) | 1.91503007 |
| 146 | Chest pain (HP:0100749) | 1.88944270 |
| 147 | Foot dorsiflexor weakness (HP:0009027) | 1.87444011 |
| 148 | Urinary incontinence (HP:0000020) | 1.86114040 |
| 149 | Abnormality of methionine metabolism (HP:0010901) | 1.85860170 |
| 150 | Muscle fiber splitting (HP:0003555) | 1.85847351 |
| 151 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.85174011 |
| 152 | Meningitis (HP:0001287) | 1.84646531 |
| 153 | Erythroderma (HP:0001019) | 1.84079708 |
| 154 | Vertigo (HP:0002321) | 1.83377656 |
| 155 | Neuronal loss in central nervous system (HP:0002529) | 1.83036411 |
| 156 | Progressive neurologic deterioration (HP:0002344) | 1.82793355 |
| 157 | Osteomyelitis (HP:0002754) | 1.81524580 |
| 158 | Memory impairment (HP:0002354) | 1.81421888 |
| 159 | Abnormality of the septum pellucidum (HP:0007375) | 1.79448535 |
| 160 | Encephalitis (HP:0002383) | 1.79001859 |
| 161 | Abnormality of the basal ganglia (HP:0002134) | 1.78567541 |
| 162 | Dementia (HP:0000726) | 1.77894527 |
| 163 | Megalencephaly (HP:0001355) | 1.77509884 |
| 164 | Poor speech (HP:0002465) | 1.77187031 |
| 165 | Decreased motor nerve conduction velocity (HP:0003431) | 1.76001554 |
| 166 | Acute encephalopathy (HP:0006846) | 1.74161964 |
| 167 | Anorexia (HP:0002039) | 1.74017440 |
| 168 | Lower limb hyperreflexia (HP:0002395) | 1.73883570 |
| 169 | Loss of speech (HP:0002371) | 1.73325018 |
| 170 | Xanthomatosis (HP:0000991) | 1.73291606 |
| 171 | Complement deficiency (HP:0004431) | 1.73002603 |
| 172 | Acute necrotizing encephalopathy (HP:0006965) | 1.71519061 |
| 173 | Premature loss of primary teeth (HP:0006323) | 1.70966207 |
| 174 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.69961442 |
| 175 | Steatorrhea (HP:0002570) | 1.69331158 |
| 176 | Clonus (HP:0002169) | 1.69261256 |
| 177 | Choreoathetosis (HP:0001266) | 1.69104778 |
| 178 | Prolonged bleeding time (HP:0003010) | 1.69036307 |
| 179 | Abolished electroretinogram (ERG) (HP:0000550) | 1.68328829 |
| 180 | Gowers sign (HP:0003391) | 1.68095488 |
| 181 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.67131081 |
| 182 | Choroideremia (HP:0001139) | 1.66726626 |
| 183 | Asymmetric septal hypertrophy (HP:0001670) | 1.65056363 |
| 184 | Mucosal telangiectasiae (HP:0100579) | 1.63488285 |
| 185 | Action tremor (HP:0002345) | 1.63017482 |
| 186 | Leukocytosis (HP:0001974) | 1.62681079 |
| 187 | Joint swelling (HP:0001386) | 1.61607625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.22299709 |
| 2 | OXSR1 | 4.58842563 |
| 3 | EPHB1 | 3.40801002 |
| 4 | RIPK4 | 3.17420894 |
| 5 | PBK | 2.92115795 |
| 6 | TYK2 | 2.80531365 |
| 7 | PKN1 | 2.70278201 |
| 8 | MAPKAPK5 | 2.63068796 |
| 9 | BCR | 2.61266206 |
| 10 | ACVR1B | 2.60883990 |
| 11 | FRK | 2.57379257 |
| 12 | WNK4 | 2.51489333 |
| 13 | IRAK4 | 2.49950855 |
| 14 | MET | 2.47761751 |
| 15 | FGFR2 | 2.34162788 |
| 16 | CDK19 | 2.13731593 |
| 17 | MAP3K14 | 2.07613622 |
| 18 | WNK1 | 2.01465554 |
| 19 | LIMK1 | 1.98204933 |
| 20 | JAK1 | 1.86128141 |
| 21 | MAP3K2 | 1.81841532 |
| 22 | NEK6 | 1.81505951 |
| 23 | TGFBR2 | 1.80460224 |
| 24 | MAP3K3 | 1.79728686 |
| 25 | CAMKK2 | 1.78310312 |
| 26 | CSNK1G3 | 1.76617131 |
| 27 | CSNK1A1L | 1.70957029 |
| 28 | MST4 | 1.65439621 |
| 29 | CAMK2B | 1.55743444 |
| 30 | FGR | 1.51484607 |
| 31 | CASK | 1.48885627 |
| 32 | TBK1 | 1.48695230 |
| 33 | YES1 | 1.47753040 |
| 34 | IKBKE | 1.47514222 |
| 35 | TXK | 1.47220875 |
| 36 | UHMK1 | 1.45814095 |
| 37 | IRAK3 | 1.40725091 |
| 38 | PRPF4B | 1.40666622 |
| 39 | CSNK1G1 | 1.40656637 |
| 40 | MAP3K12 | 1.39856519 |
| 41 | CLK1 | 1.39797991 |
| 42 | ROCK2 | 1.39453126 |
| 43 | NTRK1 | 1.38664491 |
| 44 | JAK2 | 1.38305837 |
| 45 | MAP2K3 | 1.37148741 |
| 46 | PNCK | 1.37129931 |
| 47 | JAK3 | 1.36292899 |
| 48 | TNIK | 1.35950128 |
| 49 | CAMK2D | 1.33861795 |
| 50 | SGK494 | 1.33437072 |
| 51 | SGK223 | 1.33437072 |
| 52 | TESK2 | 1.31624532 |
| 53 | CSNK1G2 | 1.30971123 |
| 54 | MATK | 1.30713025 |
| 55 | ERBB3 | 1.27859267 |
| 56 | ZAP70 | 1.27090725 |
| 57 | TAOK3 | 1.24798205 |
| 58 | TNK2 | 1.20448636 |
| 59 | FER | 1.20157160 |
| 60 | LYN | 1.19951646 |
| 61 | MAP3K1 | 1.13256662 |
| 62 | HCK | 1.11977556 |
| 63 | EPHA4 | 1.11879907 |
| 64 | EIF2AK3 | 1.11679165 |
| 65 | EPHA3 | 1.10934103 |
| 66 | IKBKB | 1.08925215 |
| 67 | CAMK2G | 1.07839104 |
| 68 | SYK | 1.06207822 |
| 69 | STK24 | 1.05795175 |
| 70 | MAPK15 | 1.05556651 |
| 71 | TEC | 1.05304525 |
| 72 | PAK6 | 1.02061536 |
| 73 | TAOK1 | 1.01390014 |
| 74 | ICK | 0.97364364 |
| 75 | PIK3CG | 0.96083328 |
| 76 | MARK3 | 0.95669016 |
| 77 | MAP4K1 | 0.94954862 |
| 78 | TIE1 | 0.93716122 |
| 79 | PRKCQ | 0.90042940 |
| 80 | FGFR3 | 0.88812204 |
| 81 | DDR2 | 0.88255773 |
| 82 | MAP3K5 | 0.87436143 |
| 83 | NEK9 | 0.87037659 |
| 84 | KIT | 0.87004950 |
| 85 | ERBB4 | 0.86606074 |
| 86 | BMPR1B | 0.86604481 |
| 87 | CAMK2A | 0.85627436 |
| 88 | TRPM7 | 0.84840605 |
| 89 | ARAF | 0.81010646 |
| 90 | DYRK2 | 0.79195889 |
| 91 | BTK | 0.78544902 |
| 92 | GRK7 | 0.76617718 |
| 93 | TAOK2 | 0.76096243 |
| 94 | PRKD1 | 0.75756140 |
| 95 | NLK | 0.75311057 |
| 96 | MUSK | 0.75257572 |
| 97 | MAP2K6 | 0.74459968 |
| 98 | PHKG1 | 0.74202853 |
| 99 | PHKG2 | 0.74202853 |
| 100 | PRKCE | 0.74081045 |
| 101 | PDPK1 | 0.73023260 |
| 102 | IRAK2 | 0.72058798 |
| 103 | CDK5 | 0.72004140 |
| 104 | CDK14 | 0.71434898 |
| 105 | PAK3 | 0.69446654 |
| 106 | MARK2 | 0.66900467 |
| 107 | MARK1 | 0.66553555 |
| 108 | SGK2 | 0.64704252 |
| 109 | DAPK2 | 0.64575471 |
| 110 | GRK6 | 0.64497251 |
| 111 | ADRBK2 | 0.64198211 |
| 112 | NTRK3 | 0.63474840 |
| 113 | CDK15 | 0.62702636 |
| 114 | ABL1 | 0.61332342 |
| 115 | RPS6KA5 | 0.60569960 |
| 116 | CAMK1G | 0.57388524 |
| 117 | CDK18 | 0.57319283 |
| 118 | ERN1 | 0.57162573 |
| 119 | FYN | 0.56062258 |
| 120 | MAP3K13 | 0.55694610 |
| 121 | PRKG1 | 0.53553565 |
| 122 | SGK3 | 0.53491154 |
| 123 | CDK11A | 0.53474638 |
| 124 | ITK | 0.52361239 |
| 125 | KSR2 | 0.52154592 |
| 126 | WNK3 | 0.52103106 |
| 127 | PIK3CA | 0.51567486 |
| 128 | EGFR | 0.51563063 |
| 129 | PRKAA2 | 0.51507724 |
| 130 | CSF1R | 0.50572617 |
| 131 | SIK3 | 0.50262926 |
| 132 | GSK3A | 0.48861634 |
| 133 | PRKCH | 0.47196464 |
| 134 | MAPK7 | 0.46865609 |
| 135 | BCKDK | 0.46329524 |
| 136 | PRKACB | 0.45989881 |
| 137 | CDK6 | 0.44889809 |
| 138 | MAPK13 | 0.44710026 |
| 139 | CSNK1D | 0.44475158 |
| 140 | CSNK1A1 | 0.40754490 |
| 141 | TYRO3 | 0.39342354 |
| 142 | STK10 | 0.39192339 |
| 143 | INSRR | 0.38944231 |
| 144 | BMPR2 | 0.37250145 |
| 145 | GRK1 | 0.37056397 |
| 146 | RAF1 | 0.36484791 |
| 147 | MAP4K2 | 0.36290181 |
| 148 | PDK1 | 0.35981141 |
| 149 | OBSCN | 0.35863437 |
| 150 | BMX | 0.35158870 |
| 151 | IRAK1 | 0.34756986 |
| 152 | PTK2B | 0.34573476 |
| 153 | PRKACA | 0.32551308 |
| 154 | BLK | 0.32283547 |
| 155 | MAP2K2 | 0.32000569 |
| 156 | MOS | 0.31128594 |
| 157 | PDK2 | 0.30767852 |
| 158 | PINK1 | 0.30743265 |
| 159 | MAPK12 | 0.30491369 |
| 160 | INSR | 0.29025975 |
| 161 | FES | 0.28080431 |
| 162 | NTRK2 | 0.27474376 |
| 163 | LCK | 0.26899111 |
| 164 | CSK | 0.26748800 |
| 165 | STK11 | 0.26533855 |
| 166 | ABL2 | 0.26426515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.53520959 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.49453564 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.48550898 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.58621430 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.25201125 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.70260705 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.63678686 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.57327095 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.54566160 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53541216 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.37185089 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.32045957 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.28274018 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.27655578 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.24503128 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19372480 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.10099471 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.07848742 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00273340 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.99284854 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99147455 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.96868582 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96002708 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95465730 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.93357176 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.87853857 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68337832 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64951137 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.62681022 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.61870264 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61245224 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60598278 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.58912980 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.55781904 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53230080 |
| 36 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.45548713 |
| 37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40487621 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39897896 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.38681365 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37030716 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.36594081 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36175375 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.35273771 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30562167 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23549582 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 1.23292395 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19020768 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18306502 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17842564 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17477227 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16788027 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16440707 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15443974 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.15115403 |
| 55 | Measles_Homo sapiens_hsa05162 | 1.12197781 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07371199 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06380575 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05805758 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04623939 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04434157 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 1.04258996 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02463038 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00947141 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.99582409 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99276225 |
| 66 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98279628 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94958101 |
| 68 | GABAergic synapse_Homo sapiens_hsa04727 | 0.93505771 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92622020 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92129324 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91793095 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.90932745 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90751792 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90004693 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88908226 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84437672 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79880805 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78402922 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77545320 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76848710 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76287088 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74730588 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74579011 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74465851 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74393246 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.73377360 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72928321 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.71087633 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69335056 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68671076 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68577843 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67700860 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66655664 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.66620392 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66457163 |
| 96 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66406144 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66025937 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65649210 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.63623946 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.63371817 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62962243 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62534754 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62462427 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61916408 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61724483 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61153977 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60808018 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58375049 |
| 109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58305767 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.57955928 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57847725 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57292325 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57258692 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.56877937 |
| 115 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56623743 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55088781 |
| 117 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52440766 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51976163 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51594224 |
| 120 | Malaria_Homo sapiens_hsa05144 | 0.50515516 |
| 121 | Long-term depression_Homo sapiens_hsa04730 | 0.50196829 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48870877 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48649194 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.48538716 |
| 125 | Hepatitis B_Homo sapiens_hsa05161 | 0.46016096 |
| 126 | Bile secretion_Homo sapiens_hsa04976 | 0.45828319 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.43843944 |
| 128 | Shigellosis_Homo sapiens_hsa05131 | 0.43751049 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43156374 |
| 130 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.41992434 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41936649 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.40179792 |
| 133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39842339 |
| 134 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39687861 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39314064 |
| 136 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38753362 |
| 137 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38476263 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37821491 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36722721 |
| 140 | Apoptosis_Homo sapiens_hsa04210 | 0.36641464 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35256150 |
| 142 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35141115 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34638280 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33856051 |
| 145 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33231422 |
| 146 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32965474 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.32766870 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32748085 |
| 149 | Phototransduction_Homo sapiens_hsa04744 | 0.32555480 |
| 150 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32305678 |
| 151 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32265717 |
| 152 | Salivary secretion_Homo sapiens_hsa04970 | 0.31915510 |
| 153 | Renin secretion_Homo sapiens_hsa04924 | 0.30687609 |
| 154 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28996562 |
| 155 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.26944042 |
| 156 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25623147 |
| 157 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25547541 |
| 158 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25285507 |
| 159 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24064353 |
| 160 | Nicotine addiction_Homo sapiens_hsa05033 | 0.23859009 |
| 161 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23566405 |
| 162 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22900716 |
| 163 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22396172 |
| 164 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.22092311 |
| 165 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.21833864 |
| 166 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21659216 |

